Transcriptomic FHITlow/pHER2high Signature As a Predictive Factor of Outcome and Immunotherapy Response in Non-Small Cell Lung Cancer
Frontiers in Immunology（2022）
Key words
NSCLC,FHIT,HER2,transcriptomic signature,prognosis,immunotherapy response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined